Table 2

Mortality results* for employees of a Canadian petroleum company, by gender, 1964–94

Cause of death (ICD codes, 8th revision)MalesFemales
O/ESMR (95% CI)O/ESMR (95% CI)
*Expected deaths based on Canadian general population mortality rates.
†95% CI does not include 1.00.
O/E, observed/expected.
All causes of death (000–999)462/711.86†0.65 (0.59 to 0.71)109/158.91†0.69 (0.56 to 0.83)
Infective & parasitic diseases (000–136)3/23.59†0.13 (0.03 to 0.37)0/1.90
Malignant neoplasms (140–209)123/163.42†0.75 (0.63 to 0.90)56/65.800.85 (0.64 to 1.10)
    Oesophagus (150)2/4.191/0.42
    Stomach (151)4/7.460.54 (0.15 to 1.37)0/1.67
    Large intestine (except rectum) (153)14/14.071.00 (0.54 to 1.67)2/4.990.40 (0.05 to 1.45)
    Rectum and rectosigmoid junction (154)4/4.621/1.10
    Liver (155.0)0/1.980/0.31
    Gall bladder (156)4/0.94†4.28 (1.17 to 10.95)0/0.52
    Pancreas (157)4/7.810.51 (0.14 to 1.31)1/2.07
    Nose & sinuses (160)2/0.350/0.7
    Bronchus & lung (162.1)35/49.81†0.70 (0.49 to 0.98)7/10.850.64 (0.26 to 1.33)
    Pleura (163.0)0/0.480/0.07
    Bone (170)0/0.950/0.25
    Malignant melanoma (172)3/4.521/1.37
    Breast (174)0/0.1820/18.451.08 (0.66 to 1.67)
    Cervix uteri (180)3/2.97
    Corpus uteri (182.0)0/0.51
    Ovary, fallopian tube, & broad ligaments (183)7/4.031.74 (0.70 to 3.58)
    Prostate (185)1/4.61
    Testis (186)3/1.61
    Bladder (188)2/2.300/0.32
    Kidney (189.0–189.2)3/4.791/0.92
    Brain (malignant) (191)11/9.291.18 (0.59 to 2.12)2/2.60
    Malignant CNS tumours (excluding brain) (192)1/0.441/0.14
    All nervous system neoplasms (malignant, benign & unspec.) (191, 192, 225, 238)12/11.021.09 (0.56 to 1.90)3/3.19
    Reticulum cell sarcoma (200.0)0/0.620/0.16
    Lymphosarcoma (200.1)0/0.731/0.18
    Hodgkin’s disease (201)3/2.501/0.63
    Non-Hodgkin’s lymphoma (200, 202.0, 202.2)5/7.450.67 (0.22 to 1.57)3/1.94
    Other lymphoid neoplasms (202.1, 202.9)1/0.450/0.11
    Multiple myeloma (203)1/2.160/0.63
    Leukaemias (204–207)7/8.180.86 (0.34 to 1.76)2/2.63
        Acute non-lymphocytic leukaemia (205.0, 206.0, 207.2)4/2.480/0.95
        Acute lymphoid leukaemia (204.0)1/0.900/0.28
        Chronic lymphoid leukaemia (204.1)1/0.750/0.12
        Acute myeloid (myelomonocytic) leukaemia (205.0)3/2.370/0.90
        Chronic myeloid leukaemia (205.1)1/1.460/0.43
        Other leukaemia (204.9, 205.9, 206.1, 206.9, 207.0–207.1, 207.9)0/2.572/0.84
Benign neoplasms (210–228)0/0.540/0.28
Endocrine, nutritional, & metabolic diseases (240–279)14/14.680.95 (0.52 to 1.60)3/3.83
    Diabetes mellitus (250)3/9.75†0.31 (0.06 to 0.90)3/2.62
    Aids (275.1)9/20.00†0.45 (0.21 to 0.85)0/0.50
Blood diseases (280–289)0/1.470/0.60
Amyotrophic lateral sclerosis (348.0)1/1.581/0.43
Circulatory diseases (390–458)112/183.20†0.61 (0.50 to 0.74)22/28.460.77 (0.48 to 1.17)
    Acute myocardial infarction (410)47/85.75†0.55 (0.40 to 0.73)4/8.580.47 (0.13 to 1.19)
    Cerebrovasular disease (430–438)13/20.760.63 (0.33 to 1.07)8/7.591.05 (0.46 to 2.08)
    Diseases of arteries, arterioles, & capillaries (440–448)5/6.680.75 (0.24 to 1.75)2/1.26
    Aortic aneurysm (441)4/3.841/0.47
Respiratory diseases (460–519)15/22.030.68 (0.38 to 1.12)2/5.900.34 (0.04 to 1.22)
    Chronic obstructive pulmonary disease (519.3)2/5.250.38 (0.05 to 1.38)1/1.08
    Digestive diseases (520–577)21/31.660.66 (0.41 to 1.01)4/6.690.60 (0.16 to 1.53)
    Cirrhosis of liver (571)13/20.050.65 (0.35 to 1.11)3/3.52
    Diseases of pancreas (577)2/1.770/0.30
    Genitourinary diseases (580–629)3/4.460/1.52
    Kidney diseases (580–593)3/4.080/1.33
    Accidents, poisonings, & violence (E800–E999)153/222.20†0.69 (0.58 to 0.81)13/31.67†0.41 (0.22 to 0.70)
    Suicide (E950–E959)44/69.84†0.63 (0.46 to 0.85)8/9.930.81 (0.35 to 1.59)